Skip to main content

Advertisement

Table 1 Patient characteristics

From: Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

Characteristic Number of patients (n = 16)
Sex
 Male 10 (62.5 %)
 Female 6 (37.5 %)
Age (years)
 Median (range) 61 (43–77)
ECOG-PS
 0 3 (18.8 %)
 1 10 (62.5 %)
 2 3 (18.8 %)
Smoking status
 Never smoker 4 (25.0 %)
 Ex-smoker 12 (75.0 %)
Pack-yearsa
 Median (range) 45.5 (17–124)
Clinical stage
 IIIA 2 (12.5 %)
 IV 4 (25.0 %)
 Recurrence 10 (62.5 %)
Diagnostic procedure
 Surgery 10 (62.5 %)
 CT-NB 3 (18.8 %)
 Autopsy 3 (18.8 %)
Pathological features
 Epithelial component
  Adenocarcinoma 7 (43.8 %)
  Squamous cell carcinoma 2 (12.5 %)
  Adenosquamous carcinoma 1 (6.3 %)
  Large cell carcinoma 4 (25.0 %)
  NOS 2 (12.5 %)
 Sarcomatoid component
  Spindle cell 0 (0.0 %)
  Giant cell 2 (12.5 %)
  Spindle cell and giant cell 14 (62.5 %)
  1. CT-NB CT-guided needle biopsy, NOS not otherwise specified
  2. aEx-smoker (n = 12)